Infection Sample Clauses
The 'Infection' clause defines the responsibilities and procedures related to the management and reporting of infectious diseases within the context of the agreement. Typically, this clause outlines the obligations of parties to notify each other if an infection is detected, implement appropriate health and safety measures, and comply with relevant laws or guidelines. For example, it may require immediate reporting of contagious illnesses or mandate specific sanitation protocols. The core function of this clause is to minimize health risks, ensure a safe environment, and clarify the steps to be taken in the event of an infection, thereby protecting all parties involved.
Infection. No Compensation is payable if the Insured Person fail to comply with or to provide the required level of proof.
Infection. 1. There will be a ten percent (10%) reduction of the stated award where the Qualified Claimant had a BMI of forty (40) or greater at the time of the Revision Surgery; and
2. There will be a fifteen percent (15%) reduction of the stated award where the Qualified Claimant had a BMI of fifty (50) or greater at the time of the Revision Surgery.
Infection. Mix 100 μl of the solution prepared in 3) and 100 μl of the 2�bacterial cultures prepared in 1) and incubate at room temperature for 10 minutes.
Infection. Suppression of the inflammatory response and immune function increases the susceptibility to infections and their severity. The risk of deterioration of bacterial, fungal, amoebic, and viral infections during glucocorticoid treatment should be carefully considered. The clinical presentation may often be atypical and serious infections such as septicaemia and tuberculosis may be masked and may reach an advanced stage before being recognised. Chickenpox: Chickenpox is of particular concern since this normally minor illness may be fatal in immunosuppressed patients. Patients without a definite history of chickenpox should be advised to avoid close personal contact with chickenpox or herpes zoster and if exposed they should seek urgent medical attention. If the patient is a child, parents must be given the above advice. Passive immunisation with varicella-zoster immunoglobulin (VZIG) is needed by exposed non-immune patients who are receiving systemic corticosteroids or who have used them within the previous 3 months; this should be given within 10 days of exposure to chickenpox. If a diagnosis of chickenpox is confirmed, the illness warrants specialist care and urgent treatment. In some cases corticosteroids should not be stopped and the dose may need to be increased.
Infection. Infection--indicated by swelling, tenderness, pain and fever--may occur in the immediate postoperative period after any type of surgery. Infection is rare after breast implant surgery and is usually treated by antibiotics; but in severe cases, drainage and implant removal may be required. CHANGES IN NIPPLE AND BREAST SENSATION Any breast surgery, including biopsy or breast implant surgery, can result in increased or decreased sensation of the breast and/or the nipple. This change can vary in degree and is usually temporary. Occasionally, changes in sensation may be permanent. INJURY TO THE BREAST IMPLANT Rarely, the implant may be weakened or torn by certain medical or surgical interventions. For example, a closed or open capsulotomy in the treatment of capsular contracture could result in such an implant injury. COSMETIC COMPLICATIONS While your surgeon takes every possible precaution, before and during surgery, to ensure a satisfactory result, there are still factors which may interfere with a satisfactory appearance of the breast after surgery. The most common reasons for dissatisfaction after breast implantation are: firmness or distortion of the breast, OTHER RISKS There have been anecdotal reports of rare, isolated or unusual breast implant problems. Please discuss all potential problems with your doctor before the surgery.
Infection. This is rare and is treated with antibiotics, or may require surgical drainage.
Infection. As a complication of septal hematoma, infection can lead to rapid resorption of the septal cartilage. Prompt drainage and antibiotics minimize the risk of infection. CSF leak is a very rare, but potentially serious, complication. It might necessitate prolonged injections. Usually settles without any further interventions. Epistaxis is an uncommon complication. May need to pack both sides and begin oral antibiotics. Persistent obstruction after resolution of postoperative edema may be due to residual deviation that was not corrected at the time of surgery. Alternatively, synechiae can form between the septum and turbinates at sites of mucosal injury. Synechiae are resolved by lysis and separation of the mucosal surfaces by placement of silastic splints. A third possibility for continued nasal obstruction is a return of the cartilaginous deviation. Options at this time include another trial of medical therapy or reoperation. Septal perforation is a complication usually encountered in the long-term postoperative period. The patient complains of crusting, epistaxis, and a whistling sound during normal respiration. Diagnosis is made by using anterior rhinoscopy, and the defect can be repaired with a variety of mucosal flaps if it is less than 1.5 cm. Cosmetic nasal deformity is a long-term complication and it is fortunately rare. This is a very rare complication and is typically transient. Congestion of both septal mucosal flaps or accumulation of bloody serous fluid under the mucoperichondrial flaps may obstruct airflow to the olfactory region, producing the symptom.
Infection. Active (draining skin lesion) Restrict from contact with patients Until lesions have resolved and patient's environment or food handling Carrier state No restriction, unless personnel are epidermiologically linked to transmission of the organism Streptococcal infection, Restrict from patient care, contact Until 24 hours after treatment group A with patient's environment or food started handling Active disease Exclude from duty Until proved noninfectious Active disease Exclude from duty Until all lesions dry and crust Post-exposure Exclude from duty From 10th day after 1st exposure through 21st day (18th day if VZIG given) after last exposure Localized (healthy person) Cover lesions; restrict from care of Until all lesions dry and crust high-risk patients Generalized or localized in immunosuppressed Restrict from patient contact Until all lesions dry and crust Post exposure Restrict from patient contact from 10th day after 1st exposure through 21st day (28th day if VZIG
Infection. Infection, although rare, can occur at the venipuncture site due to cannula or catheter placement. Infection is minimized with proper sterilization standards and has been significantly reduced with disposable collection and storage equipment.
Infection. In the situation where any member of the hirer’s party displays any Covid-19 symptoms the hirer must inform the Operator and immediately return the vehicle to the Operators location to enable the hire party to return home. In the event that the hirer fails to comply with this and remains in the vehicle beyond the hire period then the hirer will be liable to pay the full daily rate for any day or part day that they continue to occupy the vehicle beyond the end of hire date. The hirer will also be liable for any loss of earnings resulting from the Operator having to cancel subsequent bookings and for any associated cancellation costs incurred by future hirers who have been cancelled as a result of the extended occupation of the vehicle.